Unlocking the code of 14-3-3

Journal of Cell Science

Volumn 117, Issue 10, 2004, Pages 1875-1884

  Dougherty, Michele K ^a   Morrison, Deborah K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

14 3 3; Cancer; Neurodegenerative disorders; Phosphoserine; Signal transduction

Indexed keywords

APOPTOSIS INDUCING FACTOR; BINDING PROTEIN; BRAIN PROTEIN; CYTOSKELETON PROTEIN; ISOPROTEIN; ONCOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOSERINE; PHOSPHOTHREONINE; PROTEIN 14 3 3; TRANSCRIPTION FACTOR; TUBERIN; TUMOR SUPPRESSOR PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BREAST CANCER; CAENORHABDITIS ELEGANS; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CREUTZFELDT JAKOB DISEASE; CYTOLOGY; CYTOPLASM; DISEASE ASSOCIATION; DISEASE COURSE; DROSOPHILA MELANOGASTER; ENDOPLASMIC RETICULUM; EUKARYOTE; GENETIC CODE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MAMMAL; MILLER DIEKER SYNDROME; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PLANT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN TARGETING; REGULATORY MECHANISM; SCHIZOSACCHAROMYCES POMBE; SIGNAL TRANSDUCTION; SPINOCEREBELLAR DEGENERATION; STOMACH CANCER; TUBEROUS SCLEROSIS;

14-3-3 PROTEINS; ANIMALS; CYTOSKELETON; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; NEOPLASMS; NEURODEGENERATIVE DISEASES; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PLANT PROTEINS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION;

ACRONICTA LEPORINA; CAENORHABDITIS; CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; EUKARYOTA; MAMMALIA; MELANOGASTER; SCHIZOSACCHAROMYCES; SCHIZOSACCHAROMYCES POMBE;

EID: 2942552470     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.01171     Document Type: Article

References (136)

1. Abraham, D., Podar, K., Pacher, M., Kubicek, M., Welzel, N., Hemmings, B. A., Dilworth, S. M., Mischak, H., Kolch, W. and Baccarini, M. (2000). Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation. J. Biol. Chem. 275, 22300-22304.
2. Agarwal-Mawal, A., Qureshi, H. Y., Cafferty, P. W., Yuan, Z., Han, D., Lin, R. and Paudel, H. K. (2003). 14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex. J. Biol. Chem. 278, 12722-12728.
3. Aitken, A. (2002). Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants. Plant Mol. Biol. 50, 993-1010.
4. Aitken, A., Howell, S., Jones, D., Madrazo, J. and Patel, Y. (1995). 14-3-3 alpha and delta are the phosphorylated forms of raf-activating 14-3-3 beta and zeta. In vivo stoichiometric phosphorylation in brain at a Ser-Pro-Glu-Lys MOTIF. J. Biol. Chem. 270, 5706-5709.
5. Aprelikova, O., Pace, A. J., Fang, B., Koller, B. H. and Liu, E. T. (2001). BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. J. Biol. Chem. 276, 25647-25650.
6. Banfi, S., Servadio, A., Chung, M. Y., Kwiatkowski, T. J., Jr, McCall, A. E., Duvick, L. A., Shen, Y., Roth, E. J., Orr, H. T. and Zoghbi, H. Y. (1994). Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat. Genet. 7, 513-520.
7. Basu, S., Totty, N. F., Irwin, M. S., Sudol, M. and Downward, J. (2003). Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell 11, 11-23.
8. Baxter, H. C., Fraser, J. R., Liu, W. G., Forster, J. L., Clokie, S., Steinacker, P., Otto, M., Bahn, E., Wiltfang, J. and Aitken, A. (2002). Specific 14-3-3 isoform detection and immunolocalization in prion diseases. Biochem. Soc. Trans. 30, 387-391.
9. Benzing, T., Yaffe, M. B., Arnould, T., Sellin, L., Schermer, B., Schilling, B., Schreiber, R., Kunzelmann, K., Leparc, G. G., Kim, E. et al. (2000). 14-3-3 interacts with regulator of G protein signaling proteins and modulates their activity. J. Biol. Chem. 275, 28167-28172.
10. Berg, D., Holzmann, C. and Riess, O. (2003). 14-3-3 proteins in the nervous system. Nat. Rev. Neurosci. 4, 752-762.
11. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J. and Greenberg, M. E. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868.
12. Bulavin, D. V., Higashimoto, Y., Demidenko, Z. N., Meek, S., Graves, P., Phillips, C., Zhao, H., Moody, S. A., Appella, E., Piwnica-Worms, H. et al. (2003). Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nat. Cell Biol. 5, 545-551.
13. Cacace, A. M., Michaud, N. R., Therrien, M., Mathes, K., Copeland, T., Rubin, G. M. and Morrison, D. K. (1999). Identification of constitutive and ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression. Mol. Cell Biol. 19, 229-240.
14. Cahill, C. M., Tzivion, G., Nasrin, N., Ogg, S., Dore, J., Ruvkun, G. and Alexander-Bridges, M. (2001). Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways. J. Biol. Chem. 276, 13402-13410.
15. Cardoso, C., Leventer, R. J., Ward, H. L., Toyo-Oka, K., Chung, J., Gross, A., Martin, C. L., Allanson, J., Pilz, D. T., Olney, A. H. et al. (2003). Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller-Dieker syndrome, and other phenotypes secondary to deletions of 17p13.3. Am. J. Hum. Genet. 72, 918-930.
16. Castro, A. F., Rebhun, J. F., Clark, G. J. and Quilliam, L. A. (2003). Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J. Biol. Chem. 278, 32493-32496.
17. Cavet, M. E., Lehoux, S. and Berk, B. C. (2003). 14-3-3beta is a p90 ribosomal S6 kinase (RSK) isoform 1-binding protein that negatively regulates RSK kinase activity. J. Biol. Chem. 278, 18376-18383.
18. Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W. and Vogelstein, B. (1999). 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401, 616-620.
19. Chan, T. A., Hwang, P. M., Hermeking, H., Kinzler, K. W. and Vogelstein, B. (2000). Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev. 14, 1584-1588.
20. Chaudhri, M., Scarabel, M. and Aitken, A. (2003). Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo. Biochem. Biophys. Res. Commun. 300, 679-685.
21. Chen, H. K., Fernandez-Funez, P., Acevedo, S. F., Lam, Y. C., Kaytor, M. D., Fernandez, M. H., Aitken, A., Skoulakis, E. M., Orr, H. T., Botas, J. et al. (2003). Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113, 457-468.
22. Chen, M. S., Ryan, C. E. and Piwnica-Worms, H. (2003). Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol. Cell Biol. 23, 7488-7497.
23. Chiang, C. W., Kanies, C., Kim, K. W., Fang, W. B., Parkhurst, C., Xie, M., Henry, T. and Yang, E. (2003). Protein phosphatase 2A dephosphorylation of phosphoserine 112 plays the gatekeeper role for BAD-mediated apoptosis. Mol. Cell Biol. 23, 6350-6362.
24. Chong, S. S., Pack, S. D., Roschke, A. V., Tanigami, A., Carrozzo, R., Smith, A. C., Dobyns, W. B. and Ledbetter, D. H. (1997). A revision of the lissencephaly and Miller-Dieker syndrome critical regions in chromosome 17p13.3. Hum. Mol. Genet. 6, 147-155.
25. Cohen, P. T. (2002). Protein phosphatase 1-targeted in many directions. J. Cell Sci. 115, 241-256.
26. Datta, S. R., Katsov, A., Hu, L., Petros, A., Fesik, S. W., Yaffe, M. B. and Greenberg, M. E. (2000). 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell 6, 41-51.
27. del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R. and Nunez, G. (1997). Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-689.
28. Dellambra, E., Golisano, O., Bondanza, S., Siviero, E., Lacal, P., Molinari, M., D'Atri, S. and de Luca, M. (2000). Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes. J. Cell Biol. 149, 1117-1130.
29. Dhillon, A. S., Meikle, S., Yazici, Z., Eulitz, M. and Kolch, W. (2002). Regulation of Raf-1 activation and signalling by dephosphorylation. EMBO J. 21, 64-71.
30. Dobyns, W. B., Curry, C. J., Hoyme, H. E., Turlington, L. and Ledbetter, D. H. (1991). Clinical and molecular diagnosis of Miller-Dieker syndrome. Am. J. Hum. Genet. 48, 584-594.
31. Dobyns, W. B., Reiner, O., Carrozzo, R. and Ledbetter, D. H. (1993). Lissencephaly. A human brain malformation associated with deletion of the LIS1 gene located at chromosome 17p13. JAMA 270, 2838-2842.
32. Ellgaard, L. and Helenius, A. (2003). Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell. Biol. 4, 181-191.
33. Emamian, E. S., Kaytor, M. D., Duvick, L. A., Zu, T., Tousey, S. K., Zoghbi, H. Y., Clark, H. B. and Orr, H. T. (2003). Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 38, 375-387.
34. Ferguson, A. T., Evron, E., Umbricht, C. B., Pandita, T. K., Chan, T. A., Hermeking, H., Marks, J. R., Lambers, A. R., Futreal, P. A., Stampfer, M. R. et al. (2000). High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc. Natl. Acad. Sci. USA 97, 6049-6054.
35. Fu, H., Subramanian, R. R. and Masters, S. C. (2000). 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 40, 617-647.
36. Garami, A., Zwartkruis, F. J., Nobukuni, T., Joaquin, M., Roccio, M., Stocker, H., Kozma, S. C., Hafen, E., Bos, J. L. and Thomas, G. (2003). Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell 11, 1457-1466.
37. Giles, N., Forrest, A. and Gabrielli, B. (2003). 14-3-3 acts as an intramolecular bridge to regulate cdc25B localization and activity. J. Biol. Chem. 278, 28580-28587.
38. Gohla, A. and Bokoch, G. M. (2002). 14-3-3 regulates actin dynamics by stabilizing phosphorylated cofilin. Curr. Biol. 12, 1704-1710.
39. Graves, P. R., Lovly, C. M., Uy, G. L. and Piwnica-Worms, H. (2001). Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding. Oncogene 20, 1839-1851.
40. Green, A. J. (2002). Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease. Biochem. Soc. Trans. 30, 382-386.
41. Grozinger, C. M. and Schreiber, S. L. (2000). Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. USA 97, 7835-7840.
42. Hamaguchi, A., Suzuki, E., Murayama, K., Fujimura, T., Hikita, T., Iwabuchi, K., Handa, K., Withers, D. A., Masters, S. C., Fu, H. et al. (2003). Sphingosine-dependent protein kinase-1, directed to 14-3-3, is identified as the kinase domain of protein kinase C delta. J. Biol. Chem. 278, 41557-41565.
43. Hashiguchi, M., Sobue, K. and Paudel, H. K. (2000). 14-3-3zeta is an effector of tau protein phosphorylation. J. Biol. Chem. 275, 25247-25254.
44. Henriksson, M. L., Francis, M. S., Peden, A., Aili, M., Stefansson, K., Palmer, R., Aitken, A. and Hallberg, B. (2002). A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. Eur. J. Biochem. 269, 4921-4929.
45. Hermeking, H., Lengauer, C., Polyak, K., He, T. C., Zhang, L., Thiagalingam, S., Kinzler, K. W. and Vogelstein, B. (1997). 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1, 3-11.
46. Hsich, G., Kenney, K., Gibbs, C. J., Lee, K. H. and Harrington, M. G. (1996). The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 335, 924-930.
47. Inoki, K., Li, Y., Xu, T. and Guan, K. L. (2003). Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17, 1829-1834.
48. Iwata, N., Yamamoto, H., Sasaki, S., Itoh, F., Suzuki, H., Kikuchi, T., Kaneto, H., Iku, S., Ozeki, I., Karino, Y. et al. (2000). Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene 19, 5298-5302.
49. Janssens, V. and Goris, J. (2001). Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353, 417-439.
50. Jaumot, M. and Hancock, J. F. (2001). Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions. Oncogene 20, 3949-3958.
51. Jiang, K., Pereira, E., Maxfield, M., Russell, B., Goudelock, D. M. and Sanchez, Y. (2003). Regulation of Chk1 includes chromatin association and 14-3-3 binding following phosphorylation on Ser-345. J. Biol. Chem. 278, 25207-25217.
52. Jones, D. H., Ley, S. and Aitken, A. (1995). Isoforms of 14-3-3 protein can form homo- and heterodimers in vivo and in vitro: implications for function as adapter proteins. FEBS Lett. 368, 55-58.
53. Kawamoto, Y., Akiguchi, I., Nakamura, S., Honjyo, Y., Shibasaki, H. and Budka, H. (2002). 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains. J. Neuropathol. Exp. Neurol. 61, 245-253.
54. Kobayashi, T., Minowa, O., Sugitani, Y., Takai, S., Mitani, H., Kobayashi, E., Noda, T. and Hino, O. (2001). A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice. Proc. Natl. Acad. Sci. USA 98, 8762-8767.
55. Kretzschmar, H. A., Ironside, J. W., DeArmond, S. J. and Tateishi, J. (1996). Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch. Neurol. 53, 913-920.
56. Kumagai, A. and Dunphy, W. G. (1999). Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. Gene Dev. 13, 1067-1072.
57. Laronga, C., Yang, H. Y., Neal, C. and Lee, M. H. (2000). Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J. Biol. Chem. 275, 23106-23112.
58. Layfield, R., Fergusson, J., Aitken, A., Lowe, J., Landon, M. and Mayer, R. J. (1996). Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins. Neurosci. Lett. 209, 57-60.
59. Lee, V. M., Balin, B. J., Otvos, L., Jr and Trojanowski, J. Q. (1991). A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251, 675-678.
60. Lee, V. M., Goedert, M. and Trojanowski, J. Q. (2001). Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159.
61. Leffers, H., Madsen, P., Rasmussen, H. H., Honore, B., Andersen, A. H., Walbum, E., Vandekerckhove, J. and Celis, J. E. (1993). Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway. J. Mol. Biol. 231, 982-998.
62. Leventer, R. J., Cardoso, C., Ledbetter, D. H. and Dobyns, W. B. (2001). LIS1: from cortical malformation to essential protein of cellular dynamics. Trends Neurosci. 24, 489-492.
63. Li, Y., Inoki, K., Vacratsis, P. and Guan, K. L. (2003). The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3. J. Biol. Chem. 278, 13663-13671.
64. Light, Y., Paterson, H. and Marais, R. (2002). 14-3-3 antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelity. Mol. Cell. Biol. 22, 4984-4996.
65. Liu, D., Bienkowska, J., Petosa, C., Collier, R. J., Fu, H. and Liddington, R. (1995). Crystal structure of the zeta isoform of the 14-3-3 protein. Nature 376, 191-194.
66. Liu, M. Y., Cai, S., Espejo, A., Bedford, M. T. and Walker, C. L. (2002). 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). Cancer Res. 62, 6475-6480.
67. Lizcano, J. M., Morrice, N. and Cohen, P. (2000). Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem. J. 349, 547-557.
68. Lotharius, J. and Brundin, P. (2002). Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. 3, 932-942.
69. Ma, D. and Jan, L. Y. (2002). ER transport signals and trafficking of potassium channels and receptors. Curr. Opin. Neurobiol. 12, 287-292.
70. Manning, B. D. and Cantley, L. C. (2003). United at last: the tuberous sclerosis complex gene products connect the phosphomositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling. Biochem. Soc. Trans. 31, 573-578.
71. Margolis, S. S., Walsh, S., Weiser, D. C., Yoshida, M., Shenolikr, S. and Kornbluth, S. (2003). PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation. EMBO J. 22, 5734-5745.
72. Masters, S. C., Pederson, K. J., Zhang, L., Barbieri, J. T. and Fu, H. (1999). Interaction of 14-3-3 with a nonphosphorylated protein ligand, exoenzyme S of Pseudomonas aeruginosa. Biochemistry 38, 5216-5221.
73. Melis, R. and White, R. (1999). Characterization of colonic polyps by two-dimensional gel electrophoresis. Electrophoresis 20, 1055-1064.
74. Moore, B. W. and Perez, V. J. (1967). Specific Acid Proteins in the Nervous System. Englewood Cliffs, New Jersey: Prentice-Hall.
75. Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, H., Titani, K. and Ibara, Y. (1995). Proline-directed and non-proline-directed phosphorylation of PHF-tau. J. Biol. Chem. 270, 823-829.
76. Muslin, A. J., Tanner, J. W., Allen, P. M. and Shaw, A. S. (1996). Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84, 889-897.
77. Muslin, A. J. and Xing, H. (2000). 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal. 12, 703-709.
78. Nacht, M., Ferguson, A. T., Zhang, W., Petroziello, J. M., Cook, B. P., Gao, Y. H., Maguire, S., Riley, D., Coppola, G., Landes, G. M. et al. (1999). Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res. 59, 5464-5470.
79. Nellist, M., Goedbloed, M. A., de Winter, C., Verhaaf, B., Jankie, A., Reuser, A. J., van den Ouweland, A. M., van der Sluijs, P. and Halley, D. J. (2002). Identification and characterization of the interaction between tuberin and 14-3-3zeta. J. Biol. Chem. 277, 39417-39424.
80. Niu, J., Scheschonka, A., Druey, K. M., Davis, A., Reed, E., Kolenko, V., Bodnar, R., Voyno-Yasenetskaya, T., Du, X., Kehrl, J. et al. (2002). RGS3 interacts with 14-3-3 via the N-terminal region distinct from the RGS (regulator of G-protein signalling) domain. Biochem. J. 365, 677-684.
81. Nomura, M., Shimizu, S., Sugiyama, T., Narita, M., Ito, T., Matsuda, H. and Tsujimoto, Y. (2003). 14-3-3 interacts directly with and negatively regulates pro-apoptotic Bax. J. Biol. Chem. 278, 2058-2065.
82. O'Kelly, I., Butler, M. H., Zilberberg, N. and Goldstein, S. A. (2002). Forward transport. 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals. Cell 111, 577-588.
83. Obsil, T., Ghirlando, R., Klein, D. C., Ganguly, S. and Dyda, F. (2001). Crystal structure of the 14-3-3zeta: serotonin N-acetyltransferase complex. a role for scaffolding in enzyme regulation. Cell 105, 257-267.
84. Onda, H., Lueck, A., Marks, P. W., Warren, H. B. and Kwiatkowski, D. J. (1999). Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J. Clin. Invest. 104, 687-695.
85. Ory, S., Zhou, M., Conrads, T. P., Veenstra, T. D. and Morrison, D. K. (2003). Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr. Biol. 13, 1356-1364.
86. Ostergaard, M., Rasmussen, H. H., Nielsen, H. V., Vorum, H., Orntoft, T. F., Wolf, H. and Celis, J. E. (1997). Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res. 57, 4111-4117.
87. Ostrerova, N., Petrucelli, L., Farrer, M., Mehta, N., Choi, P., Hardy, J. and Wolozin, B. (1999). alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. J. Neurosci. 19, 5782-5791.
88. Ozoe, F., Kurokawa, R., Kobayashi, Y., Jeong, H. T., Tanaka, K., Sen, K., Nakagawa, T., Matsuda, H. and Kawamukai, M. (2002). The 14-3-3 proteins Rad24 and Rad25 negatively regulate Byr2 by affecting its localization in Schizosaccharomyces pombe. Mol. Cell. Biol. 22, 7105-7119.
89. Pastorino, J. G., Tafani, M. and Farber, J. L. (1999). Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositide-3-OH kinase-dependent pathway. J. Biol. Chem. 274, 19411-19416.
90. Pearson, R. B. and Kemp, B. E. (1991). Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods Enzymol. 200, 62-81.
91. Peng, C.-Y., Graves, P. R., Thomas, R. S., Wu, Z., Shaw, A. S. and Piwnica-Worms, H. (1997). Miotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25c on serine 216. Science 277, 1501-1505.
92. Peng, C. Y., Graves, P. R., Ogg, S., Thoma, R. S., Byrnes, M. J., Wu, Z., Stephenson, M. T. and Piwnica-Worms, H. (1998). C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth Differ. 9, 197-208.
93. Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F. and Zigmond, M. J. (2002). A role for alpha-synuclein in the regulation of dopamine biosynthesis. J. Neurosci. 22, 3090-3099.
94. Petosa, C., Masters, S. C., Bankston, L. A., Pohl, J., Wang, B., Fu, H. and Liddington, R. C. (1998). 14-3-3zeta binds a phosphorylated Raf peptide and an unphosphorylated peptide via its conserved amphipathic groove. J. Biol. Chem. 273, 16305-16310.
95. Powell, D. W., Rane, M. J., Joughin, B. A., Kalmukova, R., Hong, J. H., Tidor, B., Dean, W. L., Pierce, W. M., Klein, J. B., Yaffe, M. B. et al. (2003). Proteomic identification of 14-3-3zeta as a mitogen-activated protein kinase-activated protein kinase 2 substrate: role in dimer formation and ligand binding. Mol. Cell. Biol. 23, 5376-5387.
96. Prasad, G. L., Valverius, E. M., McDuffie, E. and Cooper, H. L. (1992). Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells. Cell Growth Differ. 3, 507-513.
97. Reiner, O., Albrecht, U., Gordon, M., Chianese, K. A., Wong, C., Gal-Gerber, O., Sapir, T., Siracusa, L. D., Buchberg, A. M., Caskey, C. T. et al. (1995). Lissencephaly gene (LIS1) expression in the CNS suggests a role in neuronal migration. J. Neurosci. 15, 3730-3738.
98. Reynolds, C. H., Betts, J. C., Blackstock, W. P., Nebreda, A. R. and Anderton, B. H. (2000). Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J. Neurochem. 74, 1587-1595.
99. Rittinger, K., Budman, J., Xu, J., Volinia, S., Cantley, L. C., Smerdon, S. J., Gamblin, S. J. and Yaffe, M. B. (1999). Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. Mol. Cell 4, 153-166.
100. Rosenquist, M., Alsterfjord, M., Larsson, C. and Sommarin, M. (2001). Data mining the Arabidopsis genome reveals fifteen 14-3-3 genes. Expression is demonstrated for two out of five novel genes. Plant Physiol. 127, 142-149.
101. Sanchez, Y., Wong, C., Thoma, R., Richman, R., Wu, Z., Piwnica-Worms, H. and Elledge, S. (1997). Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regultion through Cdc25. Science 277, 1497-1501.
102. Santoro, M. M., Gaudino, G. and Marchisio, P. C. (2003a). The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration. Dev. Cell 5, 257-271.
103. Santoro, M. M., Gaudino, G. and Villa-Moruzzi, E. (2003b). Protein phosphatase 1 binds to phospho-Ser-1394 of the macrophage-stimulating protein receptor. Biochem. J. 376, 587-594.
104. Seimiya, H., Sawada, H., Muramatsu, Y., Shimizu, M., Ohko, K., Yamane, K. and Tsuruo, T. (2000). Involvement of 14-3-3 proteins in nuclear localization of telomerase. EMBO J. 19, 2652-2661.
105. Servadio, A., Koshy, B., Armstrong, D., Antalffy, B., Orr, H. T., Zoghbi, H. Y., Waymire, J. C., Lin, E., Liu, J. J., Guo, F. et al. (1995). Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nat. Genet. 10, 94-98.
106. Shumway, S. D., Li, Y. and Xiong, Y. (2003). 14-3-3beta binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin. J. Biol. Chem. 278, 2089-2092.
107. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R. and Goedert, M. (1997). Alpha-synuclein in Lewy bodies. Nature 388, 839-840.
108. Suzuki, H., Itoh, F., Toyota, M., Kikuchi, T., Kakiuchi, H. and Imai, K. (2000). Inactivation of the 14-3-3 sigma gene is associated with 5′ CpG island hypermethylation in human cancers. Cancer Res. 60, 4353-4357.
109. Tan, Y., Demeter, M. R., Ruan, H. and Comb, M. J. (2000). BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival. J. Biol. Chem. 275, 25865-25869.
110. Tang, S. J., Suen, T. C., McInnes, R. R. and Buchwald, M. (1998). Association of the TLX-2 homeodomain and 14-3-3eta signaling proteins. J. Biol. Chem. 273, 25356-25363.
111. Tee, A. R., Manning, B. D., Roux, P. P., Cantley, L. C. and Blenis, J. (2003). Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activatingg protein complex toward Rheb. Curr. Biol. 13, 1259-1268.
112. Toyo-oka, K., Shionoya, A., Gambello, M. J., Cardoso, C., Leventer, R., Ward, H. L., Ayala, R., Tsai, L. H., Dobyns, W., Ledbetter, D. et al. (2003). 14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome. Nat. Genet. 34, 274-285.
113. Tzivion, G. and Avruch, J. (2002). 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J. Biol. Chem. 277, 3061-3064.
114. Ubl, A., Berg, D., Holzmann, C., Kruger, R., Berger, K., Arzberger, T., Bornemann, A. and Riess, O. (2002). 14-3-3 protein is a component of Lewy bodies in Parkinson's disease - mutation analysis and association studies of 14-3-3 eta. Brain Res. Mol. Brain Res. 108, 33-39.
115. Umbricht, C. B., Evron, E., Gabrielson, E., Ferguson, A., Marks, J. and Sukumar, S. (2001). Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene 20, 3348-3353.
116. van Hemert, M. J., Steensma, H. Y. and van Heusden, G. P. (2001). 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. Bioessays 23, 936-946.
117. Vercoutter-Edouart, A. S., Lemoine, J., le Bourhis, X., Louis, H., Boilly, B., Nurcombe, V., Revillion, F., Peyrat, J. P. and Hondermarck, H. (2001). Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells. Cancer Res. 61, 76-80.
118. Wang, B., Yang, H., Liu, Y. C., Jelinek, T., Zhang, L., Ruoslahti, E. and Fu, H. (1999). Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. Biochemistry 38, 12499-12504.
119. Wang, W. and Shakes, D. C. (1996). Molecular evolution of the 14-3-3 protein family. J. Mol. Evol. 43, 384-398.
120. Wang, Y., Waldron, R. T., Dhaka, A., Patel, A., Riley, M. M., Rozengurt, E. and Colicelli, J. (2002). The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins. Mol. Cell. Biol. 22, 916-26.
121. Waterman, M. J., Stavridi, E. S., Waterman, J. L. and Halazonetis, T. D. (1998). ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19, 175-178.
122. Wiltfang, J., Otto, M., Baxter, H. C., Bodemer, M., Steinacker, P., Bahn, E., Zerr, I., Kornhuber, J., Kretzschmar, H. A., Poser, S. et al. (1999). Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J. Neurochem. 73, 2485-2490.
123. Woodcock, J. M., Murphy, J., Stomski, F. C., Berndt, M. C. and Lopez, A. F. (2003). The dimeric versus monomeric status of 14-3-3zeta is controlled by phosphorylation of Ser58 at the dimer interface. J. Biol. Chem. 278, 36323-36327.
124. Xiao, B., Smerdon, S. J., Jones, D. H., Dodson, G. G., Soneji, Y., Aitken, A. and Gamblin, S. J. (1995). Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature 376, 188-191.
125. Xu, J., Kao, S. Y., Lee, F. J., Song, W., Jin, L. W. and Yankner, B. A. (2002). Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med. 8, 600-606.
126. Yaffe, M. B. (2002). How do 14-3-3 proteins work? Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett. 513, 53-57.
127. Yaffe, M. B., Rittinger, K., Volinia, S., Caron, P. R., Aitken, A., Leffers, H., Gamblin, S. J., Smerdon, S. J. and Cantley, L. C. (1997). The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91, 961-971.
128. Yang, H. Y., Wen, Y. Y., Chen, C. H., Lozano, G. and Lee, M. H. (2003). 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Mol. Cell. Biol. 23, 7096-7107.
129. Yang, J., Winkler, K., Yoshida, M. and Kornbluth, S. (1999). Maintenance of G2 arrest in the Xenopus oocyte: a role for 14-3-3-mediated inhibition of Cdc25 nuclear import. EMBO J. 18, 2174-2183.
130. Young, J. and Povey, S. (1998). The genetic basis of tuberous sclerosis. Mol. Med. Today 4, 313-319.
131. Yuan, H., Michelsen, K. and Schwappach, B. (2003). 14-3-3 dimers probe the assembly status of multimeric membrane proteins. Curr. Biol. 13, 638-646.
132. Yue, S., Serra, H. G., Zoghbi, H. Y., Orr, H. T., Waymire, J. C., Lin, E., Liu, J. J., Guo, F. and Zigmond, M. J. (2001). The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract. Hum. Mol. Genet. 10, 25-30.
133. Zha, J., Harada, H., Yang, E., Jockel, J. and Korsmeyer, S. J. (1996). Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87, 619-628.
134. Zhai, J., Lin, H., Shamim, M., Schlaepfer, W. W. and Canete-Soler, R. (2001). Identification of a novel interaction of 14-3-3 with p190RhoGEF. J. Biol. Chem. 276, 41318-41324.
135. Zhang, Y., Gao, X., Saucedo, L. J., Ru, B., Edgar, B. A. and Pan, D. (2003). Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol. 5, 578-581.
136. Zhou, M., Horita, D. A., Waugh, D. S., Byrd, R. A. and Morrison, D. K. (2002). Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR). J. Mol. Biol. 315, 435-446.